Safety of glycoprotein IIb/IIIa inhibitors in patients under therapeutic hypothermia admitted for an acute coronary syndrome
G Jiménez-Brítez, X Freixa, E Flores, D Penela… - Resuscitation, 2016 - Elsevier
Background Mild therapeutic hypothermia (MTH) is associated with an increased risk of both
thrombotic and bleeding events. Although little is known about the use of Glycoprotein IIb-IIIa
inhibitors (GPi) in this setting, the early action and the intravenous administration of these
agents in patients who cannot swallow might potentially translate into clinical benefits in
patients with acute coronary syndromes (ACS). Aims To assess the incidence of
bleeding/thrombotic events in patients with ACS under MTH after an Out-of-hospital cardiac …
thrombotic and bleeding events. Although little is known about the use of Glycoprotein IIb-IIIa
inhibitors (GPi) in this setting, the early action and the intravenous administration of these
agents in patients who cannot swallow might potentially translate into clinical benefits in
patients with acute coronary syndromes (ACS). Aims To assess the incidence of
bleeding/thrombotic events in patients with ACS under MTH after an Out-of-hospital cardiac …
以上显示的是最相近的搜索结果。 查看全部搜索结果